Emisphere Technologies Inc. (NASDAQ:EMIS) of Hawthorne,N.Y., announced Thursday that it will receive an interimpayment from Sandoz Pharma Ltd. to continue studies todetermine the feasibility of Emisphere's proprietary oral drugdelivery system (ODS) in the administration of an injectableproduct from Sandoz.

(c) 1997 American Health Consultants. All rights reserved.

No Comments